Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008
Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study Source: Eur Respir J 2004; 24: Suppl. 48, 87s Year: 2004
Are GINA guidelines used correctly to assess asthma severity? – a retrospective study Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020
What predicts poor collection of medication among children with asthma? A case-control study Source: Eur Respir J 2002; 20: 1464-1469 Year: 2002
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
A personalised management programme of difficult asthma: a prospective study Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Assessment of asthma control based on French guidelines criteria. Results from a pharmacy-based study Source: Eur Respir J 2006; 28: Suppl. 50, 684s Year: 2006
Medication use and disease control of asthma patients in Flanders: a cross-sectional community pharmacy study Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005
The value of additional testing in physician diagnosed asthma: A prospective pilot study Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012
AUDIPOC: Spanish national clinical audit on COPD exacerbations. Results from the initial selection of cases Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009
Are COPD prescription patterns aligned with guidelines? a population-based study Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021